Nerve growth factor (NGF) is a polypeptide growth factor that plays critical roles in the differentiation of immature neuroblasts and the subsequent survival of a subpopulation of mature neurons in both the peripheral as well as central nervous systems. Although the precise mechanism of NGF actions remains incompletely undefined, NGF initiates neuronal diffentiation by binding to the receptor tyrosine kinase (TRK A). This induces the phosphorylation of TRK A on intracellular tyrosine residues which recruits downstream signal transducing enzymes as well as adaptor proteins that contain only the Src homology (SH) domains 2 and 3. Formation of this receptor-signal transducing complex mediates the numerous cellular responses that ultimately lead to a diffentiated neuronal phenotype. Paradoxically, activation of other receptor tyrosine kinases by their cognate ligands, such as the binding of epidermal growth factor (EGF) to its receptor, also appears to initiate a similar spectrum of downstream biochemical events and yet, these growth factors induce mitogenesis rather than differentiation. This dichotomy of action suggests that downstream events are critical in determining the cellular consequences of receptor tyrosine kinase activation. The long term goal of our work is to understand the biochemical and molecular events accompanying NGF actions, and to delineate how NGF signaling promotes neuritogenesis. We have established a model system which can augment, or inhibit NGF induced neurite formation by the ectopic expression of the v-Crk adaptor molecule, or SH2 mutant v-Crk proteins, respectively, in the neural chest cell line PC12. This model system will be used to dissect the mechanisms encoding differentiative signaling . Specifically we propose to: (1.) Identify the intracellular substrates that interact with v-Crk to determine which pathways are critical for neuritogeneis. V-crk, or mutant v-Crk proteins will be expressed in PC12 cells by gene transfer to delineate the domains of v-Crk which regulate neuronal differentiation. We will also explore the potential role of v-Crk associated phosphatase/s in modulating trk receptor signaling . (2.) Determine the role of native adaptor proteins and v-Crk in linking activated receptor tyrosine kinased to the cytoskeleton. (3.) Characterize the trk A/crk/cytoskeletal interactions which result in enhanced receptor internalization.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS030687-08
Application #
6139496
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Program Officer
Chiu, Arlene Y
Project Start
1993-01-01
Project End
2001-08-31
Budget Start
2000-01-01
Budget End
2001-08-31
Support Year
8
Fiscal Year
2000
Total Cost
$240,058
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
201373169
City
New York
State
NY
Country
United States
Zip Code
10065
Ma, Qian; Yang, Jianmin; Milner, Teresa A et al. (2017) SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease. JCI Insight 2:
Harward, Stephen C; Hedrick, Nathan G; Hall, Charles E et al. (2016) Autocrine BDNF-TrkB signalling within a single dendritic spine. Nature 538:99-103
Ma, Qian; Yang, Jianmin; Li, Thomas et al. (2015) Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease. Neurobiol Dis 82:466-477
Anastasia, Agustin; Barker, Phillip A; Chao, Moses V et al. (2015) Detection of p75NTR Trimers: Implications for Receptor Stoichiometry and Activation. J Neurosci 35:11911-20
Song, Minseok; Giza, Joanna; Proenca, Catia C et al. (2015) Slitrk5 Mediates BDNF-Dependent TrkB Receptor Trafficking and Signaling. Dev Cell 33:690-702
Lee, Bridgin G; Anastasia, Agustin; Hempstead, Barbara L et al. (2015) Effects of the BDNF Val66Met Polymorphism on Anxiety-Like Behavior Following Nicotine Withdrawal in Mice. Nicotine Tob Res 17:1428-35
Hempstead, B L (2014) Deciphering proneurotrophin actions. Handb Exp Pharmacol 220:17-32
Fulmer, Clifton G; VonDran, Melissa W; Stillman, Althea A et al. (2014) Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination. J Neurosci 34:8186-96
Irmady, Krithi; Jackman, Katherine A; Padow, Victoria A et al. (2014) Mir-592 regulates the induction and cell death-promoting activity of p75NTR in neuronal ischemic injury. J Neurosci 34:3419-28
Yang, Jianmin; Harte-Hargrove, Lauren C; Siao, Chia-Jen et al. (2014) proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep 7:796-806

Showing the most recent 10 out of 52 publications